Clinical Trial

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage…

3 months ago

N=1 Collaborative Welcomes Hugh Hempel as Executive Director to Lead the Next Phase of Growth

Industry veteran brings expertise to scale patient access to life-changing individualized therapiesBOSTON, MA / ACCESSWIRE / October 3, 2024 /…

3 months ago

Steady Growth for ONCare Alliance With the Addition of Two New Practices in Nebraska and Illinois

Opportunities for Collaboration Continue to Draw Independent Large and Small Practices From Across the CountryPUYALLUP, WA / ACCESSWIRE / October…

3 months ago

The Largest Network of Research Sites Vetted to Execute Complexities of Cell & Gene Therapy (CGT) Trials Now Includes 1,500 Sites

Advarra's Gene Therapy Ready (GTR) global site network expands to better support and accelerate the rapidly growing number of CGT…

3 months ago

180 Life Sciences Corp. – Corporate Updates

Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance SheetPALO ALTO, CA /…

3 months ago

Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe…

3 months ago

AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Robert Edwards, MD, UPMC, Magee-Womens Hospital Robert Edwards, MD, UPMC, Magee-Womens Hospital Thomas Equels, CEO of AIM ImmunoTech Inc Thomas…

3 months ago

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Annovis Bio Inc. (NYSE: ANVS) announces the availability of a broadcast…

3 months ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on…

3 months ago